Insomnia and Poor venous access
Summary:
Poor venous access is found among people with Insomnia, especially for people who are male, 40-49 old.
The study analyzes which people have Poor venous access with Insomnia. It is created by eHealthMe based on reports of 53 people who have Insomnia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Insomnia?
Insomnia (sleeplessness) is found to be associated with 3,116 drugs and 5,173 conditions by eHealthMe. Check the latest studies of Insomnia.
What is Poor venous access?
Poor venous access is found to be associated with 678 drugs and 480 conditions by eHealthMe. Check the latest studies of Poor venous access.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
53 people who have Insomnia and Poor Venous Access are studied.

Gender of people who have Insomnia and experienced Poor Venous Access *:
- female: 41.38 %
- male: 58.62 %
Age of people who have Insomnia and experienced Poor Venous Access *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 8.7 %
- 20-29: 4.35 %
- 30-39: 8.7 %
- 40-49: 47.83 %
- 50-59: 8.7 %
- 60+: 21.74 %
Common co-existing conditions for these people *:
- Pain: 31 people, 58.49%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 28 people, 52.83%
- Cellulitis (infection under the skin): 21 people, 39.62%
- Diarrhea: 21 people, 39.62%
- Stress And Anxiety: 8 people, 15.09%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 11.32%
- Osteoporosis (bones weak and more likely to break): 6 people, 11.32%
- Depression: 5 people, 9.43%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 7.55%
- Constipation: 4 people, 7.55%
Common drugs taken by these people *:
- Vitamin B12: 22 people, 41.51%
- Colestid: 22 people, 41.51%
- Inflectra: 19 people, 35.85%
- Rogaine: 13 people, 24.53%
- Viagra: 13 people, 24.53%
- Ativan: 8 people, 15.09%
- Azathioprine: 8 people, 15.09%
- Prednisone: 7 people, 13.21%
- Loperamide Hydrochloride: 6 people, 11.32%
- Hydromorphone Hydrochloride: 6 people, 11.32%
Common symptoms for these people *:
- Migraine (headache): 22 people, 41.51%
- Herpes Zoster: 21 people, 39.62%
- Hair Loss: 21 people, 39.62%
- Post Procedural Infection: 21 people, 39.62%
- High Blood Pressure: 17 people, 32.08%
- Fatigue (feeling of tiredness): 16 people, 30.19%
- Pain: 15 people, 28.30%
- Toothaches (tooth pain): 13 people, 24.53%
- Dyspnea (difficult or laboured breathing): 12 people, 22.64%
- Staphylococcal Skin Infection (skin infection by an infection with staphylococcus bacteria): 12 people, 22.64%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Poor venous access?
- Check whether Poor venous access is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Insomnia (438,087 reports)
- Poor venous access (14,290 reports)
All the drugs that are associated with Poor venous access:
- Poor venous access (678 drugs)
All the conditions that are associated with Poor venous access:
- Poor venous access (480 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Poor venous access and Insomnia, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Xywav cause Drowsiness? - a second ago
- Could Relpax cause Aseptic Necrosis? - a second ago
- Could Metformin Hydrochloride cause Pain Exacerbated? - 4 seconds ago
- Hyperlipidaemia and Amyotrophic Lateral Sclerosis - 14 seconds ago
- Restless Leg Syndrome and drugs of ingredients of glucosamine sulfate - 14 seconds ago
- Could Cisplatin cause Diffuse Alveolar Damage? - 15 seconds ago
- Drug interactions of Botox and Eliquis - 16 seconds ago
- Could Albuterol cause Thrombocytopenia? - 22 seconds ago
- Could Qvar cause Gastrointestinal Disorder? - 27 seconds ago
- Could Xtandi cause Central Nervous System Lesion? - 37 seconds ago